IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,293 | +89.0% | 33,700 | -6.6% | 0.01% | +100.0% |
| Q2 2023 | $684 | -61.1% | 36,100 | -68.2% | 0.00% | 0.0% |
| Q1 2023 | $1,758 | +175.1% | 113,400 | +215.0% | 0.00% | 0.0% |
| Q4 2022 | $639 | -99.6% | 36,000 | +32.8% | 0.00% | +200.0% |
| Q3 2022 | $151,000 | +43.8% | 27,100 | 0.0% | 0.00% | – |
| Q2 2022 | $105,000 | -29.5% | 27,100 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $149,000 | -35.2% | 27,100 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $230,000 | +223.9% | 27,100 | +230.5% | 0.00% | – |
| Q3 2021 | $71,000 | -83.1% | 8,200 | -9.9% | 0.00% | -100.0% |
| Q4 2020 | $420,000 | +37.3% | 9,100 | +4.6% | 0.00% | +100.0% |
| Q3 2020 | $306,000 | +157.1% | 8,700 | +77.6% | 0.00% | 0.0% |
| Q2 2020 | $119,000 | – | 4,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |